Get started
Author

Rachel S. van Leeuwaarde

Observed names: Leeuwaarde, R. van, Leeuwaarde, Rachel van, R S van Leeuwaarde, R. S. Van Leeuwaarde, R. S. van Leeuwaarde, R. van Leeuwaarde, R.S. Van Leeuwaarde, R.S. van Leeuwaarde, Rachel Leeuwaarde, Rachel S van Leeuwaarde, Rachel S. Van Leewaarde, Rachel Sara van Leeuwaarde, Rachel van Leeuwaarde, Rachel S. van Leeuwaarde, Van Leeuwaarde, R., Van Leeuwaarde, Rachel S., van Leeuwaarde, MD, PhD Rachel S. S., van Leeuwaarde, R.S., van Leeuwaarde, Rachel S, van Leeuwaarde, Rachel S., van Leeuwaarde, Rachel Sara
ORCID: 0000-0001-6147-9746
Observed ORCID: 0000-0001-6147-9746
OpenAlex ID: A5083744454
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
2023 · Talya L. Dayton, Nicolas Alcala, et al. · Cancer Cell · 86
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study
2020 · Arthur J A T Braat, Rutger C G Bruijnen, et al. · The Lancet Oncology · 79
Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1—Results From the Dutch MEN1 Study Group
2017 · Carolina R C Pieterman, Joanne M de Laat, et al. · The Journal of Clinical Endocrinology & Metabolism · 78
PDF
MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group
2017 · Rachel S. van Leeuwaarde, Koen M. Dreijerink, et al. · The Journal of Clinical Endocrinology & Metabolism · 70
PDF
Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base
2018 · Mark J C van Treijen, Dirk-Jan van Beek, et al. · Journal of the Endocrine Society · 62
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group
2021 · Jette J. Bakhuizen, Helen Hanson, et al. · Familial Cancer · 61
PDF
The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis
2020 · Marceline W. Piek, Emily L. Postma, et al. · Thyroid · 60
The Importance of an Early and Accurate MEN1 Diagnosis
2018 · Joanne M. de Laat, Rachel S. van Leeuwaarde, et al. · Frontiers in Endocrinology · 59
PDF
Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
2018 · Mark J. C. van Treijen, Catharina M. Korse, et al. · Frontiers in Endocrinology · 57
PDF
Management recommendations for pancreatic manifestations of von Hippel–Lindau disease
2021 · Shachar Laks, Rachel van Leeuwaarde, et al. · Cancer · 54
PDF
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group
2016 · Rachel S. van Leeuwaarde, Bernadette P. M. van Nesselrooij, et al. · The Journal of Clinical Endocrinology & Metabolism · 52
PDF
High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group
2018 · Rachel S van Leeuwaarde, Carolina R C Pieterman, et al. · The Journal of Clinical Endocrinology & Metabolism · 46
PDF
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?
2020 · Elettra Merola, Teresa Alonso Gordoa, et al. · The Oncologist · 45
PDF
The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group
2020 · Medard F M van den Broek, Joanne M de Laat, et al. · The Journal of Clinical Endocrinology & Metabolism · 33
PDF
Health-Related Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1
2020 · Rachel S. van Leeuwaarde, Carolina R.C. Pieterman, et al. · Neuroendocrinology · 31
PDF
First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands
2019 · Ludwike van Kalmthout, Arthur Braat, et al. · Clinical Nuclear Medicine · 29
PDF
Multidisciplinary integrated care pathway for von Hippel–Lindau disease
2022 · Wendy P. G. Wolters, Koen M. A. Dreijerink, et al. · Cancer · 27
PDF
The future: medical advances in MEN1 therapeutic approaches and management strategies
2017 · Rachel S van Leeuwaarde, Joanne M de Laat, et al. · Endocrine Related Cancer · 27
PDF
Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA)
2023 · S. C. Ebbers, M. W. Barentsz, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 24
PDF
Self‐management support in patients with adrenal insufficiency
2016 · Nick T.M. van der Meij, Rachel S. van Leeuwaarde, et al. · Clinical Endocrinology · 23
The incidence of consecutive manifestations in Von Hippel-Lindau disease
2019 · Anouk N. A. van der Horst-Schrivers, Wim J. Sluiter, et al. · Familial Cancer · 21
PDF
Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas: A Systematic Review
2019 · Medard F. M. van den Broek, Bernadette P. M. van Nesselrooij, et al. · Frontiers in Endocrinology · 20
PDF
‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1
2018 · Dirk-Jan van Beek, Rachel S van Leeuwaarde, et al. · Endocrine Connections · 19
PDF
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression
2021 · Johannes F Fahrmann, Amanda R Wasylishen, et al. · The Journal of Clinical Endocrinology & Metabolism · 18
Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series
2021 · Medard F. M. van den Broek, Ester B. G. Rijks, et al. · Endocrine · 17
PDF
Works count: 100
Citation count: 1,375
H-index: 21
I10-index: 39
Year
Topic
Type